Lansoprazole Pellets
Enteric-coated lansoprazole pellets providing rapid acid control with low ash content for clean compression runs.
Product overview
Lansoprazole is a proton pump inhibitor used in acid-related gastrointestinal therapies. Its acid-labile nature makes controlled enteric protection an important part of pellet formulation. Rraynex processes Lansoprazole Pellets with controlled particle size, coating, moisture, and dissolution characteristics to support reliable downstream manufacturing.
Key characteristics
- Enteric-coated delayed-release platform.
- Uniform pellet morphology for capsule filling.
- Controlled coating for gastro-resistance.
- Suitable for MUPS and multiparticulate development.
- Bulk pharmaceutical supply for formulation and commercial programs.
Product specifications
- Product
- Lansoprazole Pellets
- Form
- Pellets
- Therapeutic category
- Anti-Ulcerant (PPIs)
- Available strengths
- 8.5%, 12.5%, 30%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Lansoprazole Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities